These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15756629)

  • 41. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM; Clement Y; Rouse J; Matthew J; Asgarali Z; Ramoutar D; Teelucksingh S
    Int J Clin Pharmacol Res; 2003; 23(2-3):69-74. PubMed ID: 15025036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
    Inoue H; Komori M; Matsumoto T; Fukuyama S; Matsumura M; Nakano T; Tsuda M; Matsumoto K; Kanaya A; Moriwaki A; Aizawa H; Yoshida M; Nakanishi Y
    Respiration; 2007; 74(6):611-6. PubMed ID: 16960440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
    Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".
    Koenig SM; Ostrom N; Pearlman D; Waitkus-Edwards K; Yancey S; Prillaman BA; Dorinsky P
    J Asthma; 2008 Oct; 45(8):681-7. PubMed ID: 18951261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Asthma control over 3 years in a real-life study.
    Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; James M
    Respir Med; 2009 Mar; 103(3):348-55. PubMed ID: 19042115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare.
    Nguyen WT; Stewart C; Fisher K; Tolley E; Lew DB; Self TH
    Allergy Asthma Proc; 2005; 26(2):129-34. PubMed ID: 15971472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma.
    Ernst P; Franssen E; Chan CK; Okell M; O'Byrne P; Bai T
    Respir Med; 2008 Jan; 102(1):77-81. PubMed ID: 17904834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of switching from salmeterol/fluticasone to formoterol/ budesonide combinations in patients with uncontrolled asthma.
    Akamatsu T; Shirai T; Kato M; Hashimoto D; Yasui H; Inui N; Suda T; Yokomura K; Hayakawa H; Ide K; Toyoshima M; Kuroishi S; Yasuda K; Suganuma H; Yamada T; Masuda M; Chida K
    Allergol Int; 2012 Jun; 61(2):323-9. PubMed ID: 22441635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population.
    Friedman H; Wilcox T; Reardon G; Crespi S; Yawn BP
    Clin Ther; 2008 Oct; 30(10):1908-17. PubMed ID: 19014847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient-reported outcomes among omalizumab and salmeterol/fluticasone combination therapy patients.
    Miller DP; Tom G; Rasouliyan L; Chipps B
    J Asthma; 2009 Mar; 46(2):179-85. PubMed ID: 19253127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minimal tolerance to the bronchoprotective effect of inhaled salmeterol/fluticasone combination on allergene challenge.
    Paggiaro PL; Giannini D; Di Franco A; Bacci E; Dente FL; Vagaggini B; Tonelli M; Zingoni M
    Pulm Pharmacol Ther; 2006; 19(6):425-9. PubMed ID: 16326121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of theophylline plus salmeterol/fluticasone propionate combination therapy in patients with asthma.
    Nie H; Zhang G; Liu M; Ding X; Huang Y; Hu S
    Respir Med; 2013 Mar; 107(3):347-54. PubMed ID: 23290154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation].
    Wettengel R; Steinkamp G
    Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma.
    Chanez P; Stallaert R; Reznikova E; Bloemen P; Adamek L; Joos G
    Respir Med; 2010 Aug; 104(8):1101-9. PubMed ID: 20452196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients.
    Maneechotesuwan K; Assawabhumi J; Rattanasaengloet K; Suthamsmai T; Pipopsuthipaiboon S; Udompunturak S
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S91-100. PubMed ID: 24772585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study.
    Ohbayashi H; Shibata N; Hirose T; Adachi M
    Pulm Pharmacol Ther; 2009 Dec; 22(6):574-9. PubMed ID: 19683591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Montelukast and airway remodeling in children with chronic persistent asthma: an open study.
    Pifferi M; Caramella D; Ragazzo V; De Marco E; Pietrobelli A; Boner AL
    Pediatr Allergy Immunol; 2004 Oct; 15(5):472-3. PubMed ID: 15482525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.